Ennov

ennov.com · Paris, France

Ennov provides regulatory, quality, clinical, and pharmacovigilance software solutions for life sciences and other regulated industries, offering a unified platform to manage compliance, content, and data across the product lifecycle. Its products help pharmaceutical, biotech, medical device, and related organizations digitize and streamline processes such as submissions, safety reporting, quality management, and clinical trial documentation. The company generates revenue through licensing and subscriptions to its software suite, along with related implementation and support services.

Revenue
$10M - $50M
Employees
201 - 1,000
Founded
1999
Headquarters
Paris, France

Ennov customers on Arbolus

Total customers 37 35 current · 2 former
Reviews growth 11 new reviews since Apr 2026

Customers who reviewed Ennov

Seniority of Ennov customers

The largest group of people who reviewed Ennov holds C-Suite roles (43%), followed by Director (41%) and Manager (16%).

  • C-Suite 43%
  • Director 41%
  • Manager 16%

Customers sample

Product Leader Manager NPS 8 Will renew
Strategy Leader C-Suite NPS 7 Undecided
Operations Leader C-Suite NPS 8 Undecided

Employer names and spend open in the full report, along with the other 34 customers.

What 37 Arbolus experts think of Ennov

Overall sentiment: Positive

NPS responses are generally positive, with most ratings in the 7–9 range and only a minority below 6. 60% of experts show intent to renew or maintain spend, though some, particularly Influencers, remain 'not sure' or decline intent. Customers are predominantly at the More Than 1 Year implementation stage, correlating to increased satisfaction and higher spend brackets. Key themes include praise for cost-effectiveness, robust compliance, and unified architecture but note requests for deeper AI, streamlined integration, and improvement in user experience.

Everything 37 customers told us about Ennov.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

-5 Net Promoter Score, from 37 scored reviews
  • Promoters 7
  • Passives 21
  • Detractors 9

Praised

  • Regulatory Specialization and Workflow Depth
  • On-Premise Deployment Option
  • Unified Compliance and Cost Effectiveness
  • Broader End-to-End Clinical Offering

Criticised

  • Customer Care and AI Improvement
  • AI and User Experience Limitations
  • Integration and Customization Complexity
  • Switching Risk from Delayed Innovation

What Ennov customers say

Regulatory Specialization and Workflow Depth

“I value Ennov for its competitive, intuitive workflows managing complex global submissions and registrations, significantly lowering compliance risk.”

Other Analyst · Health Care · 10,000+ employees · North America

On-Premise Deployment Option

“A key differentiator for us is that Ennov offers on-premise deployment, unlike many competitors, which is crucial for regulated clinical trial environments.”

Operations Leader · Health Care · 10,000+ employees · EMEA

Unified Compliance and Cost Effectiveness

“We rely on Ennov because it provides quality, regulatory, and pharmacovigilance solutions in a single integrated platform at a much lower cost.”

Product Leader · Health Care · 10,000+ employees · EMEA

Renewal intent

Plan to renew 52%
  • Will renew 13
  • Undecided 10
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 27% 11 answers
  • Director 67% 9 answers
  • Manager 80% 5 answers
  • 8.1/10 Average score from customers who will renew
  • 6.9/10 Average score from undecided customers
  • 4.5/10 Average score from customers not renewing

Top alternatives

Most weighed by Ennov customers
Ennov alternatives, ranked by customers →

Report

Sep 2026 37 + 0

For people who use Ennov

Do you use Ennov at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 37 customers of Ennov have already contributed

Takes a few minutes. Your identity stays anonymous.